@Egonolsen: Willkommen zurück.
@Egonolsen: Willkommen zurück.
Viele Grüße
Thomas
https://www.thiele-judo.de/portal/
The reality is, you can say ANYTHING you want. You just have to be willing to face the consequences of your choice.
.
Relativ aktuell vom European Centre for Disease Prevention and Control zum Thema (zweite) Booster Dosis:
https://www.ecdc.europa.eu/sites/def...oster-dose.pdf
Key messages
...
• All EU/EEA countries are currently recommending a first booster dose at a defined interval following primary vaccination.
At present, uptake of the first booster dose in the EU/EEA adult population is 64.2% (country range 11.0−87.9%).
• In general, vaccine effectiveness (VE) against infection due to Omicron has been shown to be reduced compared
to other SARS-CoV-2 variants, and protection wanes over time.
• Published literature indicates VE against severe outcomes caused by Omicron remains high, with continued strong
protection in the range of 80−90% around 2−3 months after receiving the first booster, albeit with some evidence
of this waning slightly from around 3-4 months. In addition, analysis of severe outcomes among COVID-19 cases
having received a first booster dose, as reported to TESSy, also shows that hospitalisation and death are extremely
rare in this group; 0.38% and 0.1% respectively. Moreover, the adjusted risk of hospitalisation and death is higher
in older populations, males and those who received a first booster dose more than three months ago.
• Evidence currently available indicates that a second mRNA booster dose is able to restore the humoral immune
response to levels similar to those observed shortly after the first booster dose, and also to restore VE against
infection, although this does appear to wane rapidly. Early data indicate that the risk of severe disease and/or
death due to COVID-19 is reduced for up to 10 weeks after the administration of a second booster dose, compared
to those receiving only the first booster dose. However, this is in populations already experiencing low levels of
severe outcomes, thus providing small absolute reductions. The maximum duration of this protection is not yet
known due to the short follow-up periods after the second booster in the studies available.
• Mathematical modelling suggests that increasing the proportion of the population who have been provided with
immunity through a primary course and first booster has a substantial potential to reduce COVID-19 death burden
by the end of October 2022. This is particularly relevant for countries where gaps in coverage are still large, and
efforts to address these gaps remain a public health priority. With regard to the second booster, modelling shows
that its roll-out in some vulnerable groups could avert a substantial proportion of COVID-19 deaths between now
and mid-autumn 2022. Further indications are set out below.
− The total number of averted deaths, both before and beyond autumn 2022, depends on the COVID-19
incidence, and as such is difficult to predict with certainty.
− To reduce future COVID-19 burden through a second booster, the effect per dose is highest when targeting
vulnerable populations, such as older age groups.
− Given that vaccination and the boosting of immunity achieves the maximum impact at population level if
administered before an epidemic wave and the minimum impact if administered at the end of an epidemic
ECDC TECHNICAL REPORT Public health considerations to support decisions on implementing a second mRNA COVID-19 vaccine booster dose
wave, a continuous high incidence or a large surge in cases in the early summer would imply greater benefit
could be achieved by an early second booster roll-out. Alternatively, if surveillance shows relatively low
incidence levels during the summer months, the optimal timing for a second booster roll-out would be later in
the year, subject to further assessment of the risk of a surge in cases during autumn/winter 2022 and waning
protection against severe outcome.
• Given data on the current epidemiological situation, vaccine effectiveness and mathematical modelling, it is
suggested that EU/EEA countries consider the information set out below with respect to the administration of a
second COVID-19 booster dose.
− Due to the fragility of the population, continued high hospitalisation and ICU rates in many settings, lower
immune response to vaccination, and the higher risk of severe COVID-19, the public health benefit of
administering a second booster dose is clearest in those aged 80 years and above. Immediate administration of
a second booster dose in this population would be optimal in situations of continued high or increasing viral
circulation. Alternatively, in situations of low viral circulation, administration of a second booster dose should be
considered prior to autumn 2022.
− Mathematical modelling suggests that a second booster roll-out including those aged 60-79 years who are
immunocompetent in the EU/EEA is likely to be beneficial, although the best timing for the roll-out depends on the
highly uncertain future of COVID-19 incidence. Therefore, continued close epidemiological and vaccine
effectiveness monitoring is essential in order to rapidly detect signals of increased SARS-CoV-2 circulation or risk
of severe COVID-19 among vaccinated individuals. If such signals emerge, a second booster may be considered
for all or some adults between the ages of 60 and 79 years and countries should have plans in place for a rapid
deployment of booster doses in this population group.
− For immunocompetent individuals below 60 years of age, the administration of a second booster dose at this
time is not supported by the current epidemiological, modelling or VE data on the continued level of vaccine
protection against severe disease or death.
...
Impfung und Impfzentren: BILD verrät, wie es geht
https://www.bild.de/politik/kolumnen...3478.bild.html
in unserem stadtteil und auch in anderen gemeinden mussten die meisten ins zentrum, weil viele hausärzte lieber dort an freinen freien tagen impften, als es in der praxis zu tun...
Geändert von marq (16-05-2022 um 11:45 Uhr)
Relativ aktuell vom European Centre for Disease Prevention and Control zum Thema (zweite) Booster Dosis:
https://www.ecdc.europa.eu/sites/def...oster-dose.pdfDeckt sich mit meiner Alltagsumfelderfahrung.However, this is in populations already experiencing low levels of
severe outcomes, thus providing small absolute reductions. The maximum duration of this protection is not yet
known due to the short follow-up periods after the second booster in the studies available.
"We are voices in our head." - Deadpool
Beim impfen gibt es in Berlin größere preisunterschiede:
https://m.bild.de/politik/kolumnen/p...ildMobile.html
https://www.thelancet.com/journals/l...271-7/fulltext
4. Boosterimpfung bringt entgegen aktueller Behauptungen große Vorteile.
Zitat von focus.de
https://www.tagesschau.de/eilmeldung...richt-101.htmlEinrichtungsbezogene Impfpflicht ist zulässig
Die Impfpflicht gegen das Coronavirus für bestimmte Berufsgruppen bleibt bestehen. Das hat das Bundesverfassungsgericht entschieden und damit Klagen von Mitarbeitenden aus dem Gesundheitswesen abgewiesen.
ich bin mir sicher, dass auch eine allgemeine impfpflicht vor dem gericht bestand gehabt hätte.
Ist allerdings auch nur Show-Lauf, da in den allermeisten Fällen wohl keinerlei Konsequenzen aus der Nicht-Impfung folgen (z. B. hier: https://www.medienservice.sachsen.de...n/news/1044987)
Demnach sind bisher 4.332 Meldungen von Einrichtungen und Unternehmen, die unter die einrichtungsbezogene Impfpflicht zählen, eingegangen. Dabei wurden 23.625 Personen gemeldet, die keinen oder keinen vollständigen Nachweis vorgelegt haben.
Von diesen 23.625 gemeldeten Personen, wurden bisher 12.780 Personen durch die Gesundheitsämter zum Vorlegen der Nachweise aufgefordert.
Keines der Gesundheitsämter hat bisher ein Betretungs- oder ein Tätigkeitsverbot gegenüber einer nachweissäumigen Person ausgesprochen. Auch ein Bußgeld gegen eine Person oder eine Einrichtung bzw. ein Unternehmen wurde bisher nicht verhängt.
Ich schrieb ja nicht, dass es nie und nirgends Konsequenzen hat.
Dein Artikel handelt von zwei Mitarbeitern, der (neuere) von mir verlinkte betrifft ganz Sachsen.
Inwieweit das wirklich umgesetzt wird, bleibt doch eher noch abzuwarten.
Auch von Bayern scheint da nichts zu erwarten sein (https://www.infranken.de/ueberregion...nd-art-5439645) - einzelne Heime natürlich ausgenommen.
Ebenso BW:
https://www.swr.de/swraktuell/baden-...in-bw-100.html
Ich vermute eher, dass die wieder abgeschafft wird.
Geändert von Gast (19-05-2022 um 13:16 Uhr)
allerdings unterstützt bayern erneut eine impfpflicht ab 60:
https://www.br.de/nachrichten/deutsc...anlauf,T65HvhI
Aktive Benutzer in diesem Thema: 5 (Registrierte Benutzer: 0, Gäste: 5)